134 related articles for article (PubMed ID: 7829909)
1. [In vitro antibacterial activity of fleroxacin (FLRX) against clinical isolates from bacterial enteritis].
Imagawa Y; Fukuyama M; Kawakami K; Suda O
Kansenshogaku Zasshi; 1994 Nov; 68(11):1409-16. PubMed ID: 7829909
[TBL] [Abstract][Full Text] [Related]
2. [In vitro antibacterial activity of pazufloxacin (PZFX) against clinical isolates from infectious enteritis].
Fukuyama M; Oonaka K; Hara M; Imagawa Y
Kansenshogaku Zasshi; 1996 Jan; 70(1):51-9. PubMed ID: 8822053
[TBL] [Abstract][Full Text] [Related]
3. [In vitro antibacterial activity of balofloxacin (BLFX) against isolates from patients with bacterial enteritis].
Fukuyama M; Kawakami K; Suda O; Imagawa Y
Kansenshogaku Zasshi; 1995 Sep; 69(9):987-90. PubMed ID: 7594800
[TBL] [Abstract][Full Text] [Related]
4. [Basic and clinical studies of fleroxacin on infectious enteritis. Research Group of AM-833 on infectious enteritis].
Sagara H; Tomizawa I; Takizawa Y; Nitta Y; Tsunoda T; Yamaguchi T; Masuda G; Negishi M; Ajisawa A; Murata M
Kansenshogaku Zasshi; 1994 Nov; 68(11):1390-408. PubMed ID: 7829908
[TBL] [Abstract][Full Text] [Related]
5. [In vitro antimicrobial activity of DR-3355, a new quinolone antibacterial agent, against clinical isolates of enteritis-causing bacteria].
Horiuchi S; Inagaki Y; Yamamoto N; Ogawa M; Nakaya R
Kansenshogaku Zasshi; 1992 Jan; 66(1):51-8. PubMed ID: 1402063
[TBL] [Abstract][Full Text] [Related]
6. [The drug susceptibility pattern of the presumed etiologic agents of infectious enteritis including verotoxin-producing Escherichia coli O-157].
Deguchi K; Suzuki Y; Ishihara R; Ishii Y; Nakazawa A
Jpn J Antibiot; 1997 Oct; 50(10):829-43. PubMed ID: 9412873
[TBL] [Abstract][Full Text] [Related]
7. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(4):253-7. PubMed ID: 2941257
[TBL] [Abstract][Full Text] [Related]
8. [In vitro antimicrobial activity of rokitamycin, a macrolide antibacterial agent, against clinically isolated strains of Campylobacter and other enteritis-causing bacteria].
Horiuchi S; Inagaki Y; Chida T; Nakaya R
Kansenshogaku Zasshi; 1991 Oct; 65(10):1325-30. PubMed ID: 1791330
[TBL] [Abstract][Full Text] [Related]
9. [Antibacterial activity of fosfomycin against the causative bacteria isolated from bacterial enteritis].
Fukuyama M; Furuhata K; Oonaka K; Hara T; Sunakawa K
Jpn J Antibiot; 2000 Jul; 53(7):522-31. PubMed ID: 11019386
[TBL] [Abstract][Full Text] [Related]
10. [In vitro antibacterial activity of norfloxacin (NFLX) against enteritis-causing bacteria].
Goto N; Horiuchi S; Okamura N; Inagaki Y; Ozawa K; Mochizuki A; Nakaya R
Kansenshogaku Zasshi; 1986 Apr; 60(4):315-21. PubMed ID: 3095460
[No Abstract] [Full Text] [Related]
11. [Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].
Habiyaremye I; Verbist L; Vandepitte J
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):800-4. PubMed ID: 3116489
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of bacterial pathogens associated with acute diarrhea in children under 5 years of age: a hospital-based cross-sectional study.
Tian L; Zhu X; Chen Z; Liu W; Li S; Yu W; Zhang W; Xiang X; Sun Z
BMC Infect Dis; 2016 Jun; 16():253. PubMed ID: 27267601
[TBL] [Abstract][Full Text] [Related]
13. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study of prulifloxacin on infectious enteritis. Japan Research Committee of Prulifloxacin, Research Group on Infectious Enteritis].
Tomizawa I; Takizawa Y; Nitta Y; Tsunoda T; Fukuda H; Yamaguchi T; Masuda G; Negishi M; Ajisawa A; Murata M; Ohnishi K; Irimajiri S; Obana M; Sajima Y; Sagara H; Kato H; Hosoda S; Banba T; Sasaki M; Yoshikawa K; Nakagawa M; Ohkubo H; Kim Y; Akao M; Fukuyama M
Kansenshogaku Zasshi; 1996 Jul; 70(7):727-45. PubMed ID: 8797308
[TBL] [Abstract][Full Text] [Related]
15. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
McCarter YS; Mazens-Sullivan MF; Bartlett RC
Chemotherapy; 1992; 38(5):308-18. PubMed ID: 1337507
[TBL] [Abstract][Full Text] [Related]
16. [The current status of infectious enteritis in Japan--reports of the "Research Group for Infectious Enteric Diseases, Japan" in the last 5 years (1996-2000)].
Obana M; Sagara H; Aoki T; Kim R; Takizawa Y; Tsunoda T; Irimajiri S; Yamashita K
Kansenshogaku Zasshi; 2002 May; 76(5):355-68. PubMed ID: 12073571
[TBL] [Abstract][Full Text] [Related]
17. [Clinical trial of T-3262 on acute enteritis. Japan Research Committee of T-3262, Research Group for Acute Infectious Enteritis].
Aoki T; Matsubara Y; Sagara H; Tomizawa I; Takizawa Y; Nitta Y; Seo T; Kamimura M; Masuda G; Negishi M
Kansenshogaku Zasshi; 1989 Jun; 63(6):593-605. PubMed ID: 2693541
[TBL] [Abstract][Full Text] [Related]
18. [Basic and clinical studies of pazufloxacin on infectious enteritis research group of T-3761 on infectious enteritis].
Sagara H; Yoshikawa K; Tomizawa I; Takizawa Y; Nitta Y; Tsunoda T; Fukuda H; Yamaguchi T; Masuda G; Negishi M; Ajisawa A; Murata M; Ohnishi K; Irimajiri S; Obana M; Matsumoto F; Imai T; Sakurai I; Takahashi T; Mori M; Mizuno Y; Katoh K; Hosoda S; Bamba T; Saito M
Kansenshogaku Zasshi; 1996 Jan; 70(1):60-72. PubMed ID: 8822054
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens.
Carlson JR; Thornton SA; DuPont HL; West AH; Mathewson JJ
Antimicrob Agents Chemother; 1983 Oct; 24(4):509-13. PubMed ID: 6651278
[TBL] [Abstract][Full Text] [Related]
20. The comparative in-vitro activity of ofloxacin.
Grüneberg RN; Felmingham D; O'Hare MD; Robbins MJ; Perry K; Wall RA; Ridgway GL
J Antimicrob Chemother; 1988 Sep; 22 Suppl C():9-19. PubMed ID: 3182468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
